Eye publishes case series of rapid cataract progression after GLP-1 therapy
The report describes asymmetric lens changes in patients receiving GLP-1 receptor agonists, adding to scattered ophthalmic safety signals around the class.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 6 20:00 ETSource: Eye (London, England)
The wire
- 01A case series in Eye reports rapid, asymmetric cataract progression in patients following GLP-1 receptor agonist therapy.
- 02Prescribers and telehealth operators handling incretin patients may field questions about vision changes alongside existing reports of ophthalmic events.
- 03A case series cannot establish causation; patient numbers, doses and follow-up are limited and confounding by diabetes and rapid weight loss is unaddressed.
From the source
Read at pubmed.ncbi.nlm.nih.govRapid asymmetric cataract progression in patients following GLP-1 receptor agonist therapy: case series
Eye (London, England) · 2026 Oct 7 · Eissa M, Hassan A, Osman M et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42839092/
